The sales are routine and immaterial relative to market cap. The derivative exercises and same-day sales pattern suggest tax withholding or 10b5-1 plan activity rather than a bearish view. No action warranted, monitor for any larger unplanned insider sales in coming weeks.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 14 $89.74entry
- T+1 · 2mo ago +5.46%α +5.92% · $94.64
- T+5 · 8w ago +9.01%α +7.36% · $97.83
- T+20 · 5w ago −28.88%α −31.15% · $63.82
- T+45 · todayOpen
- T+60 · in 21d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
GeneDx Holdings CEO Katherine Stueland and CFO Kevin Feeley sold a combined $419K in open-market shares on September 9, 2026, at $84.22 per share. The sales followed non-cash derivative exercises by both executives on the same day, suggesting a tax- or liquidity-driven pattern rather than a coordinated bearish signal. At $2.5B market cap, the sales represent ~0.017% of market cap, well below the 0.1% materiality threshold.
Key Financial Metrics
Key Facts
- CEO Stueland sold 3,692 shares at $84.22 for $311K
- CFO Feeley sold 1,285 shares at $84.22 for $108K
- Both executives exercised derivative options at $0 on the same day before selling
- Total open-market sales of $419K represent ~0.017% of $2.5B market cap
- No open-market purchases in the cluster
- Sales occurred on the same day at the same price, consistent with a single trading plan or tax-related sale
Financial Impact
$419K in insider sales, representing 0.017% of market cap, immaterial
Risk Factors
- If additional unplanned insider sales emerge in the next 30 days, the pattern could shift from routine to concerning
- The stock has been volatile (prior reports show large swings); insider sales near highs could signal caution if repeated
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-WGS-1789193556396 |
Track record
13 reports on WGS
5 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +63.51% at T+60 after the May 20, 2026 report. 7 of 7 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $52.37 Now $51.02 −2.58% settles Feb 11
- Nov 9, 20267d ago 8-K Bullish 6/10 Entry $54.83 Now $51.02 −6.95% settles Feb 8
- Nov 6, 202610d ago SC 13G Neutral 3/10 Entry $62.37 Now $51.02 −18.20% settles Feb 4
- Sep 18, 20268w ago Insider Cluster Bearish 4/10 Entry $97.83 Now $51.02 +47.85% settles Dec 15
- Sep 11, 20269w ago Insider Cluster Neutral 2/10 Viewing Entry $89.74 Now $51.02 −43.15% settles Dec 8
- Sep 1, 202610w ago 144 Neutral 2/10 Entry $86.72 Now $51.02 −41.17% settles Nov 27
- Jun 16, 202621w ago 8-K Neutral 3/10 Entry $60.60 to $83.96 Now $51.02 −15.81% ▲ +38.55% +37.55% vs SPY
- Jun 11, 202622w ago Institutional Cluster Bullish 4/10 Entry $59.92 to $85.87 Now $51.02 −14.85% ▲ +43.31% +40.04% vs SPY
- Jun 8, 202623w ago Insider Cluster Bullish 6/10 Entry $56.33 to $86.72 Now $51.02 −9.43% ▲ +53.95% +50.14% vs SPY
- May 20, 202625w ago Insider Cluster Bullish 6/10 Entry $47.33 to $77.39 Now $51.02 +7.80% ▲ +63.51% +59.21% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers